The latest price target for Tevogen Bio Holdings (NASDAQ:TVGN) was reported by D. Boral Capital on March 11, 2025. The analyst firm set a price target for $10.00 expecting TVGN to rise to within 12 months (a possible 861.54% upside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for Tevogen Bio Holdings (NASDAQ:TVGN) was provided by D. Boral Capital, and Tevogen Bio Holdings maintained their buy rating.

There is no last upgrade for Tevogen Bio Holdings

There is no last downgrade for Tevogen Bio Holdings.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tevogen Bio Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tevogen Bio Holdings was filed on March 11, 2025 so you should expect the next rating to be made available sometime around March 11, 2026.

While ratings are subjective and will change, the latest Tevogen Bio Holdings (TVGN) rating was a maintained with a price target of $10.00 to $10.00. The current price Tevogen Bio Holdings (TVGN) is trading at is $1.04, which is out of the analyst’s predicted range.